These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1664511)

  • 1. A comparison between Ki-67 antibody reactivity and other pathological variables in breast carcinoma.
    Bilous AM; McKay M; Milliken J
    Pathology; 1991 Oct; 23(4):282-5. PubMed ID: 1664511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p53 and c-erbB-2 protein expression in breast carcinomas. An immunohistochemical study including correlations with receptor status, proliferation markers, and clinical stage in human breast cancer.
    Barbareschi M; Leonardi E; Mauri FA; Serio G; Dalla Palma P
    Am J Clin Pathol; 1992 Oct; 98(4):408-18. PubMed ID: 1357956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of Ki-67 antigen expression with mitotic figure index and tumor grade in breast carcinomas using the novel "paraffin"-reactive MIB1 antibody.
    Weidner N; Moore DH; Vartanian R
    Hum Pathol; 1994 Apr; 25(4):337-42. PubMed ID: 8163266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical demonstration of cell proliferation and estrogen receptor status in human breast cancer. Analysis of 45 cases.
    Hori M; Furusato M; Nikaidoh T; Aizawa S
    Acta Pathol Jpn; 1990 Dec; 40(12):902-7. PubMed ID: 1965755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ki-67 immunostaining in node-negative stage I/II breast carcinoma. Significant correlation with prognosis.
    Sahin AA; Ro J; Ro JY; Blick MB; el-Naggar AK; Ordonez NG; Fritsche HA; Smith TL; Hortobagyi GN; Ayala AG
    Cancer; 1991 Aug; 68(3):549-57. PubMed ID: 1648433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PCNA/cyclin expression in breast carcinomas: its relationships with Ki-67, ER, PgR immunostainings and clinico-pathologic aspects.
    Tuccari G; Rizzo A; Muscarà M; Giuffrè G; Barresi G
    Pathologica; 1993; 85(1095):47-55. PubMed ID: 8100059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast carcinomas with protein S-100 immunoreactivity. An immunocytochemical and ultrastructural study.
    Lunde S; Nesland JM; Holm R; Johannessen JV
    Pathol Res Pract; 1987 Oct; 182(5):627-31. PubMed ID: 2825146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In situ distribution of oncogene products and growth factor receptors in breast carcinoma: c-erbB-2 oncoprotein, EGFr, and PDGFr-beta-subunit.
    Kommoss F; Colley M; Hart CE; Franklin WA
    Mol Cell Probes; 1990 Feb; 4(1):11-23. PubMed ID: 1969111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The immunohistochemical growth fraction (Ki-67) of breast cancers: relations to tumor spread, tumor morphology and receptor testing].
    Weikel W; Beck T; Rosenthal H; Herzog R
    Geburtshilfe Frauenheilkd; 1989 Mar; 49(3):277-82. PubMed ID: 2566552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical localization of metallothionein in human breast cancer in comparison with cathepsin D, stromelysin-1, CD44, extracellular matrix components, P53, Rb, C-erbB-2, EGFR, steroid receptor content and proliferation.
    Ioachim E; Kamina S; Demou A; Kontostolis M; Lolis D; Agnantis NJ
    Anticancer Res; 1999; 19(3A):2133-9. PubMed ID: 10470161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ki-67 reactivity in breast carcinoma analyzed by a computer-assisted image system: preliminary results.
    Mir R; Johnson H; Mathur R; Wise L; Kahn LB
    J Natl Med Assoc; 1995 Aug; 87(8):554-9. PubMed ID: 7674345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical analysis of proliferating cell nuclear antigen (PCNA) in infiltrating ductal carcinomas: comparison with clinical and pathologic variables.
    Frierson HF
    Mod Pathol; 1993 May; 6(3):290-4. PubMed ID: 8102204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Ductal carcinoma in situ: steroid receptors and proliferation kinetics].
    Ronay G; Sponsel N; Tulusan AH
    Pathologe; 1990 Nov; 11(6):327-31. PubMed ID: 1963219
    [No Abstract]   [Full Text] [Related]  

  • 14. Vimentin is preferentially expressed in human breast carcinomas with low estrogen receptor and high Ki-67 growth fraction.
    Domagala W; Lasota J; Bartkowiak J; Weber K; Osborn M
    Am J Pathol; 1990 Jan; 136(1):219-27. PubMed ID: 2153347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proliferating cell nuclear antigen immunostaining in breast cancer and its relation to prognosis.
    Narita T; Funahashi H; Satoh Y; Takagi H
    Jpn J Clin Oncol; 1993 Feb; 23(1):20-5. PubMed ID: 8096256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of tumor cell kinetics by immunohistochemistry in carcinoma of breast.
    McGurrin JF; Doria MI; Dawson PJ; Karrison T; Stein HO; Franklin WA
    Cancer; 1987 May; 59(10):1744-50. PubMed ID: 3548942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proliferative activity and steroid receptors determined by immunohistochemistry in adjacent frozen sections of 102 breast carcinomas.
    Helin ML; Helle MJ; Helin HJ; Isola JJ
    Arch Pathol Lab Med; 1989 Aug; 113(8):854-7. PubMed ID: 2667495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human milk fat globule antigen III D 5, steroid receptors and histopathologic parameters in breast cancer.
    Helle M; Helin H; Antonen J; Krohn K
    APMIS; 1988 May; 96(5):415-20. PubMed ID: 2837254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ki-67 immunoreactivity in breast carcinomas in relation to transferrin receptor expression, estrogen receptor status and morphological criteria. An immunohistochemical study.
    Wrba F; Chott A; Reiner A; Reiner G; Markis-Ritzinger E; Holzner JH
    Oncology; 1989; 46(4):255-9. PubMed ID: 2662089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Progesterone receptors in breast cancer. Comparison of immunohistochemical with biochemical receptor analysis. Relation between hormone receptor content and growth fraction (Ki-67)].
    Ronay G; Sponsel N; Merkle E; Tulusan AH
    Pathologe; 1990 Jan; 11(1):4-9. PubMed ID: 2156252
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.